Course Objective
- Describe the challenges in working with clients to understand the tenets of U=U
- Describe how U=U can be combined with other biomedical technologies to help curtail HIV infection
- Describe how HIV biomedical technologies function to counter the stigma associated with HIV
- List the barriers associated with the uptake of HIV biomedical technologies
- Describe how U=U can be leveraged to counter outdated HIV laws and policies
- Describe the role patients have in advancing U=U messages with their providers.
Date: August 7, 2018
Presenter:
Perry N. Halkitis, PhD, MS, MPH
Dean & Professor, Rutgers School of Public Health
Professor, Rutgers RWJ Medical School; Graduate School of Applied and Professional Psychology; School of Public Affairs and Administration
Director, Center for Health, Identity, Behavior & Prevention Studies (CHIBPS)
In this webinar, Dr. Perry Halkitis presents on the concept of HIV treatment as prevention. First, Dr. Halkitis provides participants with an overview of pre- and post-exposure prophylaxis (PrEP and PEP) as well as treatment as prevention (TasP). He then discusses scientific evidence for TasP and its ability to reduce HIV transmission. Lastly, Dr. Halkitis describes the current interventions and programs to increase the number of people with an undetectable viral load and the future of HIV prevention by addressing biological, psychological, and social factors simultaneously.
